651 related articles for article (PubMed ID: 31238899)
21. [Avoidance of axillary lymph node dissection in breast cancer patients with metastatic sentinel node - a pilot study].
Černá M; Zedníková I; Ňaršanská A; Svoboda T; Hes O; Záhlava J; Hlaváčková M
Rozhl Chir; 2015 Mar; 94(3):117-25. PubMed ID: 25754480
[TBL] [Abstract][Full Text] [Related]
22. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
[TBL] [Abstract][Full Text] [Related]
23. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
24. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer.
Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Luiten EJ; Rutgers EJ; Rutten HJ; Roumen RM; Nieuwenhuijzen GA
Breast Cancer Res Treat; 2015 Oct; 153(3):549-56. PubMed ID: 26358709
[TBL] [Abstract][Full Text] [Related]
25. T-stage and positive sentinel nodes ratio are the useful factors to predict non-sentinel node metastasis in breast cancer patients with macro-metastasis in the sentinel node.
Noda S; Onoda N; Asano Y; Kurata K; Kashiwagi S; Kawajiri H; Takashima T; Hirakawa K
Int J Surg; 2015 Feb; 14():56-60. PubMed ID: 25597234
[TBL] [Abstract][Full Text] [Related]
26. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
[TBL] [Abstract][Full Text] [Related]
27. Sentinel and non-sentinel lymph node metastases in patients with microinvasive breast cancer: a nationwide study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Breast Cancer Res Treat; 2019 Jun; 175(3):713-719. PubMed ID: 30877405
[TBL] [Abstract][Full Text] [Related]
28. Predictive factors of non-sentinel lymph node involvement in patients with invasive breast cancer and sentinel node micrometastases.
Friedman D; Gipponi M; Murelli F; Meszaros P; Solari N; Massa M; Depaoli F; Baccini P; Carli F; Gallo M; Cafiero F
Anticancer Res; 2013 Oct; 33(10):4509-14. PubMed ID: 24123023
[TBL] [Abstract][Full Text] [Related]
29. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H
Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376
[TBL] [Abstract][Full Text] [Related]
30. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
[TBL] [Abstract][Full Text] [Related]
31. Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma.
Cipolla C; Lupo S; Grassi N; Tutino G; Greco M; Eleonora D; Gebbia V; Valerio MR
World J Surg Oncol; 2024 Apr; 22(1):100. PubMed ID: 38627759
[TBL] [Abstract][Full Text] [Related]
32. Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS study.
Rouzier R; Uzan C; Rousseau A; Guillot E; Zilberman S; Meyer C; Estevez P; Dupre PF; Kere D; Doridot V; D'halluin G; Fritel X; Pouget N; Jankowski C; Mazouni C; Simon T; Coutant C
Br J Cancer; 2017 Apr; 116(9):1135-1140. PubMed ID: 28324891
[TBL] [Abstract][Full Text] [Related]
33. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.
Guenther JM; Hansen NM; DiFronzo LA; Giuliano AE; Collins JC; Grube BL; O'Connell TX
Arch Surg; 2003 Jan; 138(1):52-6. PubMed ID: 12511150
[TBL] [Abstract][Full Text] [Related]
34. The risk of non-sentinel metastases in primary breast cancer.
Bauerfeind IG; Kahlert S; Himsl I; Sorokina Y; Ruehl IM; Lebeau A; Linke R; Untch M; Friese K
Anticancer Res; 2007; 27(4A):1929-32. PubMed ID: 17649798
[TBL] [Abstract][Full Text] [Related]
35. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
Boler DE; Uras C; Ince U; Cabioglu N
Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
[TBL] [Abstract][Full Text] [Related]
36. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
37. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
39. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
40. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]